Alpine Immune Sciences
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Alpine Immune Sciences sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Alpine Immune Sciences: 5 sponsored US clinical trials, none currently recruiting.
Alpine Immune Sciences sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cold Agglutinin Disease, with 1 trials.
Upper-quartile sponsor footprint
Alpine Immune Sciences sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
NCT05757570
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
NCT05732402
ALPN-202 With PD-1 Inhibition in Advanced Malignancies
NCT04920383
An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies
NCT04186637
ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD
NCT04227938
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
How the Alpine Immune Sciences early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Cold Agglutinin Disease (1 trial), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Alpine Immune Sciences: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Alpine Immune Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Alpine Immune Sciences page
5 registered trials is a research-attention snapshot, not an endorsement of Alpine Immune Sciences or any single study.
- None of Alpine Immune Sciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cold Agglutinin Disease is the condition Alpine Immune Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cold Agglutinin Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Alpine Immune Sciences pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.